Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute-Frederick, NIH, MD, USA.
EMBO J. 2011 Jul 29;30(18):3714-28. doi: 10.1038/emboj.2011.250.
C/EBPβ is an auto-repressed protein that becomes post-translationally activated by Ras-MEK-ERK signalling. C/EBPβ is required for oncogene-induced senescence (OIS) of primary fibroblasts, but also displays pro-oncogenic functions in many tumour cells. Here, we show that C/EBPβ activation by H-Ras(V12) is suppressed in immortalized/transformed cells, but not in primary cells, by its 3' untranslated region (3'UTR). 3'UTR sequences inhibited Ras-induced cytostatic activity of C/EBPβ, DNA binding, transactivation, phosphorylation, and homodimerization, without significantly affecting protein expression. The 3'UTR suppressed induction of senescence-associated C/EBPβ target genes, while promoting expression of genes linked to cancers and TGFβ signalling. An AU-rich element (ARE) and its cognate RNA-binding protein, HuR, were required for 3'UTR inhibition. These components also excluded the Cebpb mRNA from a perinuclear cytoplasmic region that contains activated ERK1/2, indicating that the site of C/EBPβ translation controls de-repression by Ras signalling. Notably, 3'UTR inhibition and Cebpb mRNA compartmentalization were absent in primary fibroblasts, allowing Ras-induced C/EBPβ activation and OIS to proceed. Our findings reveal a novel mechanism whereby non-coding mRNA sequences selectively regulate C/EBPβ activity and suppress its anti-oncogenic functions.
C/EBPβ 是一种自动抑制蛋白,通过 Ras-MEK-ERK 信号通路被翻译后激活。C/EBPβ 是原代成纤维细胞中癌基因诱导衰老(OIS)所必需的,但在许多肿瘤细胞中也显示出致癌功能。在这里,我们表明,通过 H-Ras(V12) 激活的 C/EBPβ 在永生化/转化细胞中被其 3' 非翻译区(3'UTR)抑制,但在原代细胞中未被抑制。3'UTR 序列抑制了 Ras 诱导的 C/EBPβ 的细胞停滞活性、DNA 结合、反式激活、磷酸化和同源二聚化,而对蛋白表达没有显著影响。3'UTR 抑制了衰老相关的 C/EBPβ 靶基因的诱导,同时促进了与癌症和 TGFβ 信号相关的基因的表达。富含 AU 的元件(ARE)及其同源 RNA 结合蛋白 HuR 是 3'UTR 抑制所必需的。这些成分还将 Cebpb mRNA 排除在包含激活的 ERK1/2 的核周细胞质区域之外,表明 C/EBPβ 翻译的位点控制 Ras 信号的去抑制。值得注意的是,3'UTR 抑制和 Cebpb mRNA 区室化在原代成纤维细胞中不存在,允许 Ras 诱导的 C/EBPβ 激活和 OIS 进行。我们的研究结果揭示了一种新的机制,即非编码 mRNA 序列选择性调节 C/EBPβ 的活性并抑制其抗癌功能。